Amgen (AMGN) Receivables (2009 - 2026)
Amgen's quarterly Receivables came in at $9.1 billion in Q1 2026, up 12.37% year-on-year from $8.1 billion in Q1 2025, and down 4.51% quarter-over-quarter from $9.6 billion in Q4 2025.
Amgen has reported Receivables for 18 years, with the latest figure at $9.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Receivables rose 12.37% year-over-year to $9.1 billion; the trailing twelve-month figure through Mar 2026 stood at $9.1 billion (up 12.37% YoY), and the FY2025 full-year result was $9.6 billion, up 37.11% from the prior year.
- Receivables for Q1 2026 stood at $9.1 billion, down from $9.6 billion in the prior quarter.
- The five-year high for Receivables was $9.6 billion in Q4 2025, with the low at $5.1 billion in Q1 2022.
- Average Receivables over 5 years is $7.0 billion, with a median of $6.9 billion recorded in 2024.
- Year-over-year, Receivables slipped 10.17% in 2024 and surged 37.11% in 2025.
- Tracing AMGN's Receivables over 5 years: stood at $5.7 billion in 2022, then surged by 36.51% to $7.8 billion in 2023, then decreased by 10.17% to $7.0 billion in 2024, then surged by 37.11% to $9.6 billion in 2025, then fell by 4.51% to $9.1 billion in 2026.
- The last three Receivables figures came in at $9.1 billion (Q1 2026), $9.6 billion (Q4 2025), and $8.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 21.18 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 17.72 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 12.48 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 12.21 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 9.14 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 5.33 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 12.59 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 9.52 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 11.46 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.14 Bn |
| Dec 31, 2025 | 9.57 Bn |
| Sep 30, 2025 | 8.49 Bn |
| Jun 30, 2025 | 8.70 Bn |
| Mar 31, 2025 | 8.13 Bn |
| Dec 31, 2024 | 6.98 Bn |
| Sep 30, 2024 | 7.32 Bn |
| Jun 30, 2024 | 6.93 Bn |
| Mar 31, 2024 | 6.78 Bn |
| Dec 31, 2023 | 7.77 Bn |
| Sep 30, 2023 | 6.15 Bn |
| Jun 30, 2023 | 5.83 Bn |
| Mar 31, 2023 | 5.74 Bn |
| Dec 31, 2022 | 5.69 Bn |
| Sep 30, 2022 | 5.33 Bn |
| Jun 30, 2022 | 5.33 Bn |
| Mar 31, 2022 | 5.08 Bn |
| Dec 31, 2021 | 5.68 Bn |
| Sep 30, 2021 | 4.77 Bn |
| Jun 30, 2021 | 4.48 Bn |
| Mar 31, 2021 | 4.42 Bn |
| Dec 31, 2020 | 5.11 Bn |
| Sep 30, 2020 | 4.09 Bn |
| Jun 30, 2020 | 5.37 Bn |
| Mar 31, 2020 | 5.01 Bn |
| Dec 31, 2019 | 4.24 Bn |
| Sep 30, 2019 | 3.61 Bn |
| Jun 30, 2019 | 3.80 Bn |
| Mar 31, 2019 | 3.77 Bn |
| Dec 31, 2018 | 3.76 Bn |
| Sep 30, 2018 | 3.44 Bn |
| Jun 30, 2018 | 3.50 Bn |
| Mar 31, 2018 | 3.63 Bn |
| Dec 31, 2017 | 3.24 Bn |
| Sep 30, 2017 | 3.40 Bn |
| Jun 30, 2017 | 3.56 Bn |
| Mar 31, 2017 | 3.25 Bn |
| Dec 31, 2016 | 3.17 Bn |
| Sep 30, 2016 | 3.19 Bn |
| Jun 30, 2016 | 3.08 Bn |
| Mar 31, 2016 | 3.08 Bn |
| Dec 31, 2015 | 3.00 Bn |
| Sep 30, 2015 | 2.90 Bn |
| Jun 30, 2015 | 2.78 Bn |
| Mar 31, 2015 | 2.55 Bn |
| Dec 31, 2014 | 2.55 Bn |
| Sep 30, 2014 | 2.36 Bn |
| Jun 30, 2014 | 2.70 Bn |
| Mar 31, 2014 | 2.51 Bn |
| Dec 31, 2013 | 2.72 Bn |
| Sep 30, 2013 | 2.67 Bn |
| Jun 30, 2013 | 2.67 Bn |
| Mar 31, 2013 | 2.53 Bn |
| Dec 31, 2012 | 2.52 Bn |
| Sep 30, 2012 | 2.70 Bn |
| Jun 30, 2012 | 2.71 Bn |
| Mar 31, 2012 | 2.99 Bn |
| Dec 31, 2011 | 2.90 Bn |
| Sep 30, 2011 | 2.73 Bn |
| Jun 30, 2011 | 2.71 Bn |
| Mar 31, 2011 | 2.52 Bn |
| Dec 31, 2010 | 2.34 Bn |
| Sep 30, 2010 | 2.44 Bn |
| Jun 30, 2010 | 2.21 Bn |
| Mar 31, 2010 | 2.27 Bn |
| Dec 31, 2009 | 2.11 Bn |
| Sep 30, 2009 | 2.33 Bn |
| Jun 30, 2009 | 2.18 Bn |